购物车
全部删除
您的购物车当前为空
别名 JX 237
JX237 是一种高效的上皮中性氨基酸转运蛋白 B0AT1 (SLC6A19) 抑制剂,是中兴氨基酸被肝脏吸收的转运蛋白,可用于研究心血管疾病。


为众多的药物研发团队赋能,
让新药发现更简单!
JX237 是一种高效的上皮中性氨基酸转运蛋白 B0AT1 (SLC6A19) 抑制剂,是中兴氨基酸被肝脏吸收的转运蛋白,可用于研究心血管疾病。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 315 | 现货 | |
| 5 mg | ¥ 745 | 现货 | |
| 10 mg | ¥ 1,320 | 现货 | |
| 25 mg | ¥ 2,650 | 现货 | |
| 50 mg | ¥ 4,290 | 现货 | |
| 100 mg | ¥ 5,970 | 现货 | |
| 200 mg | ¥ 8,220 | 现货 |
JX237 相关产品
| 产品描述 | JX237 is a potent inhibitor of the epithelial neutral amino acid transporter protein B0AT1 (SLC6A19), a transporter protein for the uptake of neutralizing amino acids by the liver, and can be used in the study of cardiovascular disease. |
| 别名 | JX 237 |
| 分子量 | 271.15 |
| 分子式 | C11H15BrN2O |
| CAS No. | 1021125-90-5 |
| Smiles | O=C(NCC)CNC1=CC=C(Br)C(=C1)C |
| 颜色 | Yellow |
| 物理性状 | Solid |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| 溶解度信息 | DMSO: 200 mg/mL (737.6 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
评论内容